Navigation Links
Cephalon Reports Another Strong Quarter
Date:10/28/2008

49,672 (281,800) 206,587 (133,273)

INCOME TAX EXPENSE (BENEFIT) (62,371) 24,963 (4,375) 102,613

NET INCOME (LOSS) $112,043 $(306,763) $210,962 $(235,886)

BASIC INCOME (LOSS) PER

COMMON SHARE $1.64 $(4.58) $3.11 $(3.55)

DILUTED INCOME (LOSS) PER

COMMON SHARE $1.42 $(4.58) $2.79 $(3.55)

WEIGHTED AVERAGE NUMBER OF

COMMON SHARES OUTSTANDING 68,118 66,931 67,855 66,398

WEIGHTED AVERAGE NUMBER OF

COMMON SHARES OUTSTANDING-

ASSUMING DILUTION 78,920 66,931 75,580 66,398

CEPHALON, INC. AND SUBSIDIARIES

Reconciliation of GAAP Net Income to Adjusted Net Income

(Unaudited)

Three Months Ended

September 30,

2008 2007

GAAP NET (LOSS) INCOME $112,043 $(306,763)

Cost of sales adjustments 54,569 (1) 22,255 (1)

Research and development adjustments 259 (2) 15,000 (2)

Selling, general and administrative

adjustments 27,169 (3) -

Settlement reserve 7,450 (4) 369,000 (4)

Gain on extinguishment of debt - (5,319) (5)

Interest expense adjustment 3,750 (6)

Restructuring charges 1,497 (7)

Income tax adjustment (113,832) (8) (21,693) (8)

(19,138) 379,243

ADJUSTED NET INCOME $92,905 $72,480

BASIC ADJUSTED INCOME PER COMMON

SHARE $1.36
'/>"/>

SOURCE Cephalon, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19

Related biology technology :

1. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
2. Cephalon, Inc. Announces Agreement to Acquire AMRIX, A Once-Daily Extended-Release Muscle Relaxant
3. Cephalon Reinforces Important Prescribing and Dosing Information for FENTORA
4. Cephalon Submits New Drug Application for TREANDA for the Treatment of Chronic Lymphocytic Leukemia
5. Cephalon Quarterly Conference Call Invitation
6. Cephalon Announces Strong Third Quarter Financial Results
7. Cephalon Submits Supplemental New Drug Application for FENTORA
8. Cephalon Submits New Drug Application for TREANDA for the Treatment of Patients with Relapsed Indolent Non-Hodgkins Lymphoma
9. Cephalon Presentation Slides for the 26th Annual JPMorgan Healthcare Conference Now Available
10. Cephalons EFFENTORA Receives Positive Opinion from European Regulatory Authorities for the Management of Breakthrough Cancer Pain
11. Cephalon Provides Update on Regulatory Status of the FENTORA Supplemental New Drug Application
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/25/2015)... , March 25, 2015 /PRNewswire/ - SQI Diagnostics Inc. ("SQI" ... as a result of recent discussions with certain shareholders ... of the Company, after dealing with certain matters including ... meeting of shareholders on March 26, 2015 (the "Meeting") ... election of directors will take place when the Meeting ...
(Date:3/25/2015)... 2015 Accelovance, a therapeutically focused contract research ... Contract Research Organization" at the upcoming Vaccine Industry Excellence ... This is the eighth consecutive year Accelovance ... winning for "Best Contract Research Organization" in 2009, 2010, ... 2013. "We,re excited to be a finalist ...
(Date:3/25/2015)... IL (PRWEB) March 25, 2015 Having ... in the latter part of 2014, ITRA Global proudly ... Global, the International Tenant Representative Alliance, based in the ... to representing tenants and occupiers of commercial real estate. ... estate advisory firm in Poland that exclusively advises occupiers ...
(Date:3/25/2015)... 2015  18 piglets born recently are the ... scientists in the College of Agriculture and Natural Resources at ... in the field of genetic engineering. Bhanu Telugu, ... & Avian Sciences (ANSC) and Ki-Eun Park, PhD, ... genome-edited pigs using a recently developed, groundbreaking technique ...
Breaking Biology Technology:SQI Diagnostics Inc. Announces New Nominees to SQI Diagnostics Board and Adjournment of Meeting 2SQI Diagnostics Inc. Announces New Nominees to SQI Diagnostics Board and Adjournment of Meeting 3SQI Diagnostics Inc. Announces New Nominees to SQI Diagnostics Board and Adjournment of Meeting 4SQI Diagnostics Inc. Announces New Nominees to SQI Diagnostics Board and Adjournment of Meeting 5Accelovance Nominated for 2015 Vaccine Industry Excellence (ViE) Awards 2International Organization Expands its Global Reach to Warsaw, Poland 2University of Maryland Researchers Successfully Produce Genome-edited Pigs Using Revolutionary Technology 2
... Reportlinker.com announces that a new market ... catalogue: Downstream Processing ... Biologics Drives Improvement in Cost -effective ... http://www.reportlinker.com/p0316266/Downstream-Processing-in-Biopharmaceuticals---Increased-Demand-for-Biologics-Drives-Improvement-in-Cost--effective-Purification-Technologies.html Downstream ...
... from Chinese government for testing of TOGS™ 9000 ... ... if (typeof(lpUnit)==,undefined,) var lpUnit=,PRN,; --> ... s = ,; var first_result; // Results are keyed by longUrl, so we need to grab the first one. ...
... Million Public Offering ... ... --> ... // Results are keyed by longUrl, so we need to grab the first one. for (var r in data.results) ...
Cached Biology Technology:Reportlinker Adds Downstream Processing in Biopharmaceuticals - Increased Demand for Biologics Drives Improvement in Cost -effective Purification Technologies 2Reportlinker Adds Downstream Processing in Biopharmaceuticals - Increased Demand for Biologics Drives Improvement in Cost -effective Purification Technologies 3Reportlinker Adds Downstream Processing in Biopharmaceuticals - Increased Demand for Biologics Drives Improvement in Cost -effective Purification Technologies 4Reportlinker Adds Downstream Processing in Biopharmaceuticals - Increased Demand for Biologics Drives Improvement in Cost -effective Purification Technologies 5Reportlinker Adds Downstream Processing in Biopharmaceuticals - Increased Demand for Biologics Drives Improvement in Cost -effective Purification Technologies 6Reportlinker Adds Downstream Processing in Biopharmaceuticals - Increased Demand for Biologics Drives Improvement in Cost -effective Purification Technologies 7Reportlinker Adds Downstream Processing in Biopharmaceuticals - Increased Demand for Biologics Drives Improvement in Cost -effective Purification Technologies 8BioSpec Global Solutions Inc hopes to receive confirmation from Chinese government for testing of TOGS™ 9000 2BioSpec Global Solutions Inc hopes to receive confirmation from Chinese government for testing of TOGS™ 9000 3BioSpec Global Solutions Inc hopes to receive confirmation from Chinese government for testing of TOGS™ 9000 4BioSpec Global Solutions Inc hopes to receive confirmation from Chinese government for testing of TOGS™ 9000 5BioSpec Global Solutions Inc hopes to receive confirmation from Chinese government for testing of TOGS™ 9000 6BioSpec Global Solutions Inc hopes to receive confirmation from Chinese government for testing of TOGS™ 9000 7OncoGenex Pharmaceuticals, Inc. Prices $50 Million Public Offering 2OncoGenex Pharmaceuticals, Inc. Prices $50 Million Public Offering 3OncoGenex Pharmaceuticals, Inc. Prices $50 Million Public Offering 4OncoGenex Pharmaceuticals, Inc. Prices $50 Million Public Offering 5OncoGenex Pharmaceuticals, Inc. Prices $50 Million Public Offering 6OncoGenex Pharmaceuticals, Inc. Prices $50 Million Public Offering 7OncoGenex Pharmaceuticals, Inc. Prices $50 Million Public Offering 8OncoGenex Pharmaceuticals, Inc. Prices $50 Million Public Offering 9
(Date:3/4/2015)... Research and Markets ( http://www.researchandmarkets.com/research/48tj8z/global_biometrics ... "Global Biometrics Market Forecast and Opportunities, 2020" ... for biometric authentication systems is projected to grow ... The driving forces for this highly ... projects and constant development in technology. In 2014, ...
(Date:3/2/2015)... , March 2, 2015  Businesses have ... Data protection company Tharon Rankins Enterprises has announced ... provides an ultra-safe way for businesses to protect ... financial transactions. Beconux is a ... Rankins Enterprises. Functioning similarly to an ATM machine, ...
(Date:2/24/2015)... This report analyzes the worldwide markets for Iris ... for the US, Canada , ... Asia-Pacific , Middle East , and ... are provided for the period 2013 through 2020. Also, a ... and analytics are derived from primary and secondary research. Company ...
Breaking Biology News(10 mins):Global Biometrics Market Forecast and Opportunities, 2020 2Global Biometrics Market Forecast and Opportunities, 2020 3Personal Data Protection Company Launches New Product 2World Iris Biometrics Industry 2World Iris Biometrics Industry 3World Iris Biometrics Industry 4World Iris Biometrics Industry 5World Iris Biometrics Industry 6World Iris Biometrics Industry 7World Iris Biometrics Industry 8World Iris Biometrics Industry 9World Iris Biometrics Industry 10World Iris Biometrics Industry 11
... three-year study to conserve and restore endangered horse mussel ... the University,s marine research and outreach centre in Portaferry ... of Biological Sciences, will provide scientific and technological research ... to restore it. Horse mussel reefs are important ...
... The Netherlands, January 22, 2009 A growing body ... delay age-related cognitive decline, including in some cases that ... in the January 2009 issue of the Journal ... of the Center for Cellular Neurobiology; Neurodegeneration Research University ...
... Current research suggests that inflammation increases the risk ... by Ovchinnikova et al, "T cell activation leads to ... appears in the February 2009 issue of The ... disease of arterial blood vessels where fats, cholesterol, blood ...
Cached Biology News:Queen's University Belfast works to save Strangford horse mussels 2Inflammation worsens danger due to atherosclerosis 2
Request Info...
Form: Ready to use Applications: ELISA...
... Strips have hydrophobic plastic supports that retain ... with toxic/hazardous solutions. Paper segments on each ... into solution. Complementary indicator charts provide clear ... in 1pH units; In packs of 100; ...
... Pharmaceutical Development, Physician Owned Labs, Drugs of Abuse, and Industrial Testing applications. Analyzer uses ... ... ... ...
Biology Products: